asco

There's a misconception that I frequently hear about evidence-based medicine (EBM), which can equally apply to science-based medicine (SBM). Actually, there are several, but they are related. These misconceptions include the idea that EBM/SBM guidelines are a straightjacket, that they are "cookbook medicine," and that EBM/SBM should be the be-all and end-all of how to practice clinical medicine. New readers might not be familiar with the difference between EBM and SBM, and here is not the place to explain the difference in detail because this post isn't primarily about that difference. The…
As if yesterday's post weren't depressing enough, last weekend I attended the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago, which is part of the reason I didn't produce much in the way of posts about a week ago. Last Sunday, while aimlessly wandering from session to session and checking Twitter and e-mail between sessions, I noticed that a lot of people, including the official ASCO Twitter feed @ASCO, were Tweeting and re-Tweeting a link to this official story from ASCO, "Integrative Oncology Can Add Benefit to Traditional Cancer Treatments." It was…
Well, it's mid-May at 36° North, the honeysuckles are blooming, my allergies are miserable, the air is damp, and that can only mean one thing: the American Society for Clinical Oncology (ASCO) meeting is nearly upon us. Held this year beginning on 29 May, the annual ASCO meeting coincides with all sorts of announcements of miracle cancer drugs and the sound of cash changing hands. Although being held in Orlando, Florida, this is far from a Mickey Mouse operation; in fact, the buzz of bullion here rivals that of the Walt Disney empire. With the abstracts released last night at 6 pm EDT,…